Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • AYUSH drug makers to...

    AYUSH drug makers to offer alternatives to banned FDC drugs

    Written by Geeta Sharma Sharma Published On 2016-05-03T10:59:21+05:30  |  Updated On 3 May 2016 10:59 AM IST
    AYUSH drug makers to offer alternatives to banned FDC drugs
    Tamil Nadu:In response to the union government's recent ban on the fixed dose drug combinations (FDC), the Tamil Nadu Ayurveda, Siddha and Unani Drugs Manufacturers Association (TASUDMA) has announced the availability of potential traditional drugs in the Ayush systems, that can take the place of the banned FDC compositions.

    Efficacy proven, documented and with no side effects or adverse reactions these traditional drugs have been in use for years, reports the association. The Indian System of Medicine (ISM) industry in the state has demanded that the government give them the support and encouragement by issuing licenses to all the SSI units to manufacture all classical and proprietary drugs. The reassured saying that they had all the facilities and potential to manufacture traditional drugs that could act as common replacements to the FDC banned compositions.

    “ Tamil Nadu AYUSH industry has all the potential to manufacture good and efficacy proven drugs which are in use for many years and all of them are documented. The government should support by giving licences to the manufacturers”, said Vijay Mehtha, president of TASUDMA. He further stated that there were solutions for all diseases in the Siddha System which carried proven records of efficacy and they were willing to provide the drugs provided the government gave them a green signal.

    Pharmabiz reports that in an attempt to gain a stronghold for Siddha drugs the TASUDMA is planning to have a meeting with the Union Ayush minister, Mr. Mehta reported. He also stated that 400 companies manufacture Ayush drugs in the state and deliver them to the government; and that it was only recently, after a period of four years, the department of Indian systems has started issuing licenses to companies for manufacturing classical and proprietary drugs. The department he said had also appointed a new licensing authority for the state the state of Tamil Nadu.
    AyurvedaAyushBanned 344 FDC drugsSiddha and Unani Drugs Manufacturers AssociationSiddha SystemTASUDMAthe Tamil Nadu AyurvedaUnaniVijay Mehtha
    Source : Inputs from Pharma Biz

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Geeta Sharma Sharma
    Geeta Sharma Sharma
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok